A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma
Glioblastoma multiforme (GBMs) are recurrent lethal brain tumours. Recurrent GBMs often exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy. Analyses revealed that recurrent GBMs have increased tension and express high levels of glycoproteins that increase the bu...
Saved in:
Published in | Nature cell biology Vol. 20; no. 10; pp. 1203 - 1214 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.10.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Glioblastoma multiforme (GBMs) are recurrent lethal brain tumours. Recurrent GBMs often exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy. Analyses revealed that recurrent GBMs have increased tension and express high levels of glycoproteins that increase the bulkiness of the glycocalyx. Studies showed that a bulky glycocalyx potentiates integrin mechanosignalling and tissue tension and promotes a mesenchymal, stem-like phenotype in GBMs. Gain- and loss-of-function studies implicated integrin mechanosignalling as an inducer of GBM growth, survival, invasion and treatment resistance, and a mesenchymal, stem-like phenotype. Mesenchymal-like GBMs were highly contractile and expressed elevated levels of glycoproteins that expanded their glycocalyx, and they were surrounded by a stiff extracellular matrix that potentiated integrin mechanosignalling. Our findings suggest that there is a dynamic and reciprocal link between integrin mechanosignalling and a bulky glycocalyx, implying a causal link towards a mesenchymal, stem-like phenotype in GBMs. Strategies to ameliorate GBM tissue tension offer a therapeutic approach to reduce mortality due to GBM.
Barnes et al. report a dynamic and reciprocal crosstalk between tissue tension and glycocalyx bulkiness that promotes a mesenchymal, stem-like phenotype in GBM. |
---|---|
Bibliography: | V.M.W., J.M.B. and S.K. conceived the project and wrote the manuscript. V.M.W. coordinated the project, J.M.B. and S.K. conducted the mouse studies, cell signalling work, tumour phenotype analysis and public dataset mining. J.M.B. conducted the human tissue assays. R.O.B. performed the bioinformatics analyses. J.J.P., D.-H.N., J.K.S., M.L. and H.W.L provided immunostaining expertise, pathology interpretation and biospecimen selection. C.R.B. and E.C.W. synthesized the mucin mimetic glycopolymers and provided instructions on their use. F.K. performed the scanning angle interference microscopy. L.P. performed the traction force microscopy. J.C.T. performed the atomic force microscopy experiments. J.M.B. and O.M. conducted the FACS characterization of GBMs. J.N.L. generated the V737N mouse and constructed all expression constructs. K.C.H. and A.S.B. performed the mass spectrometry and analyses. G.B. and K.V.L. provided tissue and training on mouse procedures. A.A.-B. and K.O. provided reagents and training on tissue microdissection and neural stem cell culture. V.M.W., J.M.B. and S.K. wrote the manuscript. Author contributions |
ISSN: | 1465-7392 1476-4679 |
DOI: | 10.1038/s41556-018-0183-3 |